4.6 Article

Disease Severity and Mortality Can Be Independently Regulated in a Mouse Model of Experimental Graft versus Host Disease

Journal

PLOS ONE
Volume 10, Issue 2, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0118079

Keywords

-

Funding

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  2. Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)

Ask authors/readers for more resources

Graft versus host disease (GVHD) is the major limitation of allogeneic hematopoietic stem cell transplantation (HSCT) presenting high mortality and morbidity rates. However, the exact cause of death is not completely understood and does not correlate with specific clinical and histological parameters of disease. Here we show, by using a semi-allogeneic mouse model of GVHD, that mortality and morbidity can be experimentally separated. We injected bone marrow-derived dendritic cells (BMDC) from NOD2/CARD15-deficient donors into semi-allogeneic irradiated chimaeras and observed that recipients were protected from death. However, no protection was observed regarding clinical or pathological scores up to 20 days after transplantation. Protection from death was associated with decreased bacterial translocation, faster hematologic recovery and epithelial integrity maintenance despite mononuclear infiltration at day 20 post-GVHD induction with no skew towards different T helper phenotypes. The protected mice recovered from aGVHD and progressively reached scores compatible with healthy animals. Altogether, our data indicate that severity and mortality can be separate events providing a model to study transplant-related mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Endosymbiotic RNA virus inhibits Leishmania-induced caspase-11 activation

Renan V. H. de Carvalho, Djalma S. Lima-Junior, Caroline de Oliveira, Dario S. Zamboni

Summary: The New World species of intracellular protozoan parasites in the Leishmania genus can cause mucocutaneous leishmaniases. The presence of Leishmania RNA virus (LRV) in Leishmania guyanensis (L.g.) exacerbates disease and leads to the development of mucocutaneous disease. Research has shown that LRV inhibits caspase-11 activation by Leishmania, shedding light on the mechanisms through which LRV promotes disease exacerbation.

ISCIENCE (2021)

Article Biochemistry & Molecular Biology

Lipid droplet accumulation occurs early following Salmonella infection and contributes to intracellular bacterial survival and replication

Ellen Kiarely Souza, Filipe S. Pereira-Dutra, Matheus A. Rajao, Felipe Ferraro-Moreira, Taynna C. Goltara-Gomes, Tamires Cunha-Fernandes, Julia da Cunha Santos, Elisa B. Prestes, Warrison A. Andrade, Dario S. Zamboni, Marcelo T. Bozza, Patricia T. Bozza

Summary: The study found that LD formation in macrophages infected with Salmonella Typhimurium rapidly increased, depending on the viability of Salmonella and T3SS activity, and regulated by TLR signaling. LD accumulation occurs through TLR2-dependent signaling and is counter-regulated by TLR4.

MOLECULAR MICROBIOLOGY (2022)

Article Pharmacology & Pharmacy

Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage

Tiago J. Costa, Simone R. Potje, Thais F. C. Fraga-Silva, Julio A. Da Silva-Neto, Paula R. Barros, Daniel Rodrigues, Mirele R. Machado, Ronaldo B. Martins, Rosangela A. Santos-Eichler, Maira N. Benatti, Keyla S. G. de Sa, Carlos Eduardo L. Almado, Italo A. Castro, Marjorie C. Pontelli, Leonardo La Serra, Fernando S. Carneiro, Christiane Becari, Paulo Louzada-Junior, Rene D. R. Oliveira, Dario S. Zamboni, Eurico Arruda, Maria Auxiliadora-Martins, Fernanda R. C. Giachini, Vania L. D. Bonato, Natasha E. Zachara, Gisele F. Bomfim, Rita C. Tostes

Summary: This study demonstrates that SARS-CoV-2 infection impairs mitochondrial function and activates TLR9 signaling in endothelial cells, leading to inflammatory responses and endothelial dysfunction. Targeting mitochondrial metabolic pathways may offer new therapeutic strategies for COVID-19.

VASCULAR PHARMACOLOGY (2022)

Article Oncology

COVID-19 bimodal clinical and pathological phenotypes

Sabrina S. Batah, Maira N. Benatti, Li Siyuan, Wagner M. Telini, Jamile O. Barboza, Marcelo B. Menezes, Tales R. Nadai, Keyla S. G. Sa, Chirag M. Vaswani, Sahil Gupta, Dario S. Zamboni, Danilo T. Wada, Rodrigo T. Calado, Rene D. R. Oliveira, Paulo Louzada-Junior, Maria Auxiliadora-Martins, Flavio P. Veras, Larissa D. Cunha, Thiago M. Cunha, Rodrigo Luppino-Assad, Marcelo L. Balancin, Sirlei S. Morais, Ronaldo B. Martins, Eurico Arruda, Fernando Chahud, Marcel Koenigkam Santos, Andrea A. Cetlin, Fernando Q. Cunha, Claudia dos Santos, Vera L. Capelozzi, Junya Fukuoka, Rosane Duarte Achcar, Alexandre T. Fabro

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Cell Biology

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients

Marjorie C. Pontelli, Italo A. Castro, Ronaldo B. Martins, Leonardo La Serra, Flavio P. Veras, Daniele C. Nascimento, Camila M. Silva, Ricardo S. Cardoso, Roberta Rosales, Rogerio Gomes, Thais M. Lima, Juliano P. Souza, Brenda C. Vitti, Diego B. Caetite, Mikhael H. F. de Lima, Spencer D. Stumpf, Cassandra E. Thompson, Louis-Marie Bloyet, Juliana E. Toller-Kawahisa, Marcela C. Giannini, Leticia P. Bonjorno, Maria I. F. Lopes, Sabrina S. Batah, Li Siyuan, Rodrigo Luppino-Assad, Sergio C. L. Almeida, Fabiola R. Oliveira, Maira N. Benatti, Lorena L. F. Pontes, Rodrigo C. Santana, Fernando C. Vilar, Maria Auxiliadora-Martins, Pei-Yong Shi, Thiago M. Cunha, Rodrigo T. Calado, Jose C. Alves-Filho, Dario S. Zamboni, Alexandre T. Fabro, Paulo Louzada-Junior, Rene D. R. Oliveira, Sean P. J. Whelan, Fernando Q. Cunha, Eurico Arruda

Summary: SARS-CoV-2 infection can lead to lymphocytopenia and infect immune cells such as monocytes, B cells, and T cells, resulting in T cell apoptosis. Additionally, SARS-CoV-2 is frequently detected in monocytes and B cells from COVID-19 patients.

JOURNAL OF MOLECULAR CELL BIOLOGY (2022)

Article Biology

Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

Ana C. G. Salina, Douglas dos-Santos, Tamara S. Rodrigues, Marlon Fortes-Rocha, Edismauro G. Freitas-Filho, Daniel L. Alzamora-Terrel, Icaro M. S. Castro, Thais F. C. Fraga da Silva, Mikhael H. F. de Lima, Daniele C. Nascimento, Camila M. Silva, Juliana E. Toller-Kawahisa, Amanda Becerra, Samuel Oliveira, Diego B. Caetite, Leticia Almeida, Adriene Y. Ishimoto, Thais M. Lima, Ronaldo B. Martins, Flavio Veras, Natalia B. do Amaral, Marcela C. Giannini, Leticia P. Bonjorno, Maria I. F. Lopes, Maira N. Benatti, Sabrina S. Batah, Rodrigo C. Santana, Fernando C. Vilar, Maria A. Martins, Rodrigo L. Assad, Sergio C. L. de Almeida, Fabiola R. de Oliveira, Eurico Arruda Neto, Thiago M. Cunha, Jose C. Alves-Filho, Vania L. D. Bonato, Fernando Q. Cunha, Alexandre T. Fabro, Helder Nakaya, Dario S. Zamboni, Paulo Louzada-Junior, Rene D. R. Oliveira, Larissa D. Cunha

Summary: This study reveals that the engulfment of SARS-CoV-2-infected apoptotic cells by macrophages exacerbates inflammatory cytokine production and impairs the ability of macrophages to perform continual efferocytosis. Lung monocytes and macrophages from severe COVID-19 patients also show compromised efferocytic capacity.

ELIFE (2022)

Article Multidisciplinary Sciences

Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection

Leticia de Almeida, Alexandre L. N. da Silva, Tamara S. Rodrigues, Samuel Oliveira, Adriene Y. Ishimoto, Amanda A. Seribelli, Amanda Becerra, Warrison A. Andrade, Marco A. Ataide, Camila C. S. Caetano, Keyla S. G. de Sa, Natalia Pelisson, Ronaldo B. Martins, Juliano de Paula Souza, Eurico Arruda, Sabrina S. Batah, Ricardo Castro, Fabiani G. Frantz, Fernando Q. Cunha, Thiago M. Cunha, Alexandre T. Fabro, Larissa D. Cunha, Paulo Louzada-Junior, Rene D. R. de Oliveira, Dario S. Zamboni

Summary: This study identifies niclosamide as a potential FDA-approved drug for treating COVID-19 by inhibiting inflammasome activation and SARS-CoV-2 replication. Niclosamide shows strong inhibitory effects on inflammasome activation in human monocytes and PBMCs from COVID-19 patients in vitro, as well as in an in vivo mouse model of SARS-CoV-2 infection.

SCIENCE ADVANCES (2022)

Article Immunology

Inflammasome activation and CCR2-mediated monocyte-derived dendritic cell recruitment restrict Legionella pneumophila infection

Marco A. Ataide, Graziele Z. Manin, Samuel S. Oliveira, Rhanoica O. Guerra, Dario S. Zamboni

Summary: Flagellin-induced activation of NAIP/NLRC4 inflammasome and pyroptosis play critical roles in restricting Legionella pneumophila infection. In this study, we found temporal coordination of two independent innate immunity pathways, inflammasome activation and CCR2-mediated recruitment of Mo-DC, in controlling the infection. The inflammasome activation is important at the early stage of infection, while Mo-DC recruitment is crucial for efficient bacterial clearance at the late stage. Mo-DC emergence depends on CCR2-signaling and is independent of inflammasome activation and pyroptosis. Additionally, Mo-DC compartment produces the most cytokines among monocyte-derived cells in the infected lung. The simultaneous ablation of CCR2 and NLRC4 axes results in aggravated bacterial burden in the lung, indicating the interplay between inflammasome activation and CCR2-mediated immune response in restricting bacterial infection.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Oncology

Cell death induced by NLRP3-palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity

Sandra P. Palma Albornoz, Thais F. C. Fraga-Silva, Renan V. H. de Carvalho, Tamara S. Rodrigues, Ana Flavia Gembre, Romulo Silva de Oliveira, Fernanda Mesquita de Souza, Giseli Furlan Correa, Leandra N. Z. Ramalho, Daniela Carlos, Danilo C. de Almeida, Niels O. S. Camara, Dario S. Zamboni, Viviani Nardini Takahashi, Carlos A. Sorgi, Lucia H. Faccioli, Alexandra Medeiros, Diego Luis Costa, Vania L. D. Bonato

Summary: A low-grade and persistent inflammation in obesity requires the participation of NLRP3 and cell death. However, during obesity-tuberculosis comorbidity, NLRP3 signaling may play a detrimental role by inducing excessive inflammation. The study shows that NLRP3 signaling promotes cell death without affecting bacterial loads.

JOURNAL OF PATHOLOGY (2023)

Article Microbiology

Caspase-8 but not caspase-7 influences inflammasome activation to act in control of Brucella abortus infection

Raiany A. Santos, Daiane M. Cerqueira, Dario S. Zamboni, Sergio C. Oliveira

Summary: This study reveals the key role of caspase-7 in cell death during Brucella infection and highlights the important function of caspase-8 in inflammasome activation and pyroptosis.

FRONTIERS IN MICROBIOLOGY (2022)

Article Cell Biology

Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients

N. B. Amaral, T. S. Rodrigues, M. C. Giannini, M. I. Lopes, L. P. Bonjorno, P. I. S. O. Menezes, S. M. Dib, S. L. G. Gigante, M. N. Benatti, U. C. Rezek, L. L. Emrich-Filho, B. A. Sousa, S. C. L. Almeida, R. Luppino-Assad, F. P. Veras, A. H. Schneider, L. O. S. Leiria, L. D. Cunha, J. C. Alves-Filho, T. M. Cunha, E. Arruda, C. H. Miranda, A. Pazin-Filho, M. Auxiliadora-Martins, M. C. Borges, B. A. L. Fonseca, V. R. Bollela, C. M. Del-Ben, F. Q. Cunha, R. C. Santana, F. C. Vilar, D. S. Zamboni, P. Louzada-Junior, R. D. R. Oliveira

Summary: This study evaluated whether colchicine treatment was associated with the inhibition of NLRP3 inflammasome activation in patients with COVID-19. The results showed that colchicine reduced the need for supplemental oxygen and the length of hospitalization, and lowered the serum levels of Casp1p20 and IL-18 in the first two days of treatment.

INFLAMMATION RESEARCH (2023)

Article Immunology

CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation

Tamara S. Rodrigues, Camila C. S. Caetano, Keyla S. G. de Sa, Leticia Almeida, Amanda Becerra, Augusto Goncalves, Leticia de Sousa Lopes, Samuel Oliveira, Danielle P. A. Mascarenhas, Sabrina S. Batah, Bruna M. Silva, Giovanni F. Gomes, Ricardo Castro, Ronaldo B. Martins, Jonathan Avila, Fabiani G. Frantz, Thiago M. Cunha, Eurico Arruda, Fernando Q. Cunha, Helder Nakaya, Larissa D. Cunha, Alexandre T. Fabro, Paulo Louzada-Junior, Rene D. R. de Oliveira, Dario S. Zamboni

Summary: SARS-CoV-2 infection activates the NLRP3 inflammasome and leads to inflammation and severe COVID-19. Human caspase-4 (mouse caspase-11) is upregulated and activated by SARS-CoV-2, contributing to NLRP3 activation. In vivo studies using transgenic hACE2 humanized mice show that hACE2 Casp11(-/-) mice are protected from disease development, with reduced lung damage, clinical symptoms, and mortality. Analysis of human samples from fatal COVID-19 cases reveals the expression of CASP4 in patient lungs, which correlates with inflammasome components and inflammatory mediators. These findings suggest CASP4/11 as a potential target for therapeutic interventions in COVID-19.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection

Keyla S. G. de Sa, Luana A. Amaral, Tamara S. Rodrigues, Adriene Y. Ishimoto, Warrison A. C. de Andrade, Leticia de Almeida, Felipe Freitas-Castro, Sabrina S. Batah, Sergio C. Oliveira, Monica T. Pastorello, Alexandre T. Fabro, Dario S. Zamboni

Summary: In this study, it is demonstrated that Gasdermin-D (GSDMD) is activated during the early stages of Leishmania infection, promoting NLRP3 inflammasome activation without causing cell death. GSDMD is cleaved into a noncanonical fragment, indicating the subversion of host response by Leishmania. Skin biopsies from patients with leishmaniasis also show activation of NLRP3 inflammasome and GSDMD.

NATURE COMMUNICATIONS (2023)

Article Critical Care Medicine

Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology

Camila Meirelles S. Silva, Carlos Wagner S. Wanderley, Flavio Protasio Veras, Augusto Veloso Goncalves, Mikhael Haruo Fernandes Lima, Juliana Escher Toller Kawahisa, Giovanni Freitas Gomes, Daniele Carvalho Nascimento, Valter V. Silva Monteiro, Isadora Marques Paiva, Cicero Jose Luiz Ramos Almeida, Diego Brito Caetite, Juliana Costa Silva, Maria Isabel Fernandes Lopes, Leticia Pastorelli Bonjorno, Marcela Cavichioli Giannini, Natalia Brasil Amaral, Maira Nilson Benatti, Rodrigo Carvalho Santana, Luis Eduardo Alves Damasceno, Bruna Manuella Souza Silva, Ayda Henriques Schneider, Icaro Maia Santos Castro, Juan Carlo Santos Silva, Amanda Pereira Vasconcelos, Tiago Tomazini Goncalves, Sabrina Setembre Batah, Tamara Silva Rodrigues, Victor Ferreira Costa, Marjorie Cornejo Pontelli, Ronaldo B. Martins, Timna Varela Martins, Danillo Lucas Alves Esposito, Guilherme Cesar Martelossi Cebinelli, Benedito Antonio Lopes da Fonseca, Luiz Osorio Silveira Leiria, Larissa Dias Cunha, Eurico Arruda, Helder Nakaia, Alexandre Todorovic Fabro, Rene D. R. Oliveira, Dario S. Zamboni, Paulo Louzada-Junior, Thiago Mattar Cunha, Jose Carlos Farias Alves-Filho, Fernando Queiroz Cunha

Summary: This study reveals that SARS-CoV-2 virus directly activates GSDMD, leading to the production of NETs and organ damage in COVID-19. Single-cell transcriptome analysis shows increased expression of GSDMD and inflammasome-related genes in COVID-19 patients. Treatment with disulfiram inhibits NETs release and reduces organ damage in a mouse model of SARS-CoV-2 infection.

CRITICAL CARE (2022)

Article Immunology

Sepsis-Induced Immunosuppression Is Marked by an Expansion of a Highly Suppressive Repertoire of FOXP3+ T-Regulatory Cells Expressing TIGIT

Mikhael Haruo Fernandes de Lima, Carlos Hiroji Hiroki, Vanessa de Fatima Borges, Guilherme Cesar Martelossi Cebinelli, Jessica Santos, Marcos Henrique Rosa, Camila Meirelles S. Silva, Carlos Wagner S. Wanderley, Augusto Velozo Goncalves, Gustavo Fernando Silva Quirino, Dario S. Zamboni, Thiago M. Cunha, Jose-Carlos A. Filho, Fernando Q. Cunha

Summary: Our study demonstrates that interleukin 33 is pivotal in selectively expanding the T-cell immunoglobulin and ITIM domain (TIGIT)(+) T-regulatory cell repertoire in a STAT6 and M2 macrophage-dependent fashion.

JOURNAL OF INFECTIOUS DISEASES (2022)

No Data Available